Correlation Between Oncology Institute and Novo Integrated

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oncology Institute and Novo Integrated at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncology Institute and Novo Integrated into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncology Institute and Novo Integrated Sciences, you can compare the effects of market volatilities on Oncology Institute and Novo Integrated and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncology Institute with a short position of Novo Integrated. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncology Institute and Novo Integrated.

Diversification Opportunities for Oncology Institute and Novo Integrated

0.79
  Correlation Coefficient

Poor diversification

The 3 months correlation between Oncology and Novo is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Oncology Institute and Novo Integrated Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Integrated Sciences and Oncology Institute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncology Institute are associated (or correlated) with Novo Integrated. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Integrated Sciences has no effect on the direction of Oncology Institute i.e., Oncology Institute and Novo Integrated go up and down completely randomly.

Pair Corralation between Oncology Institute and Novo Integrated

Considering the 90-day investment horizon Oncology Institute is expected to generate 0.31 times more return on investment than Novo Integrated. However, Oncology Institute is 3.21 times less risky than Novo Integrated. It trades about -0.19 of its potential returns per unit of risk. Novo Integrated Sciences is currently generating about -0.15 per unit of risk. If you would invest  32.00  in Oncology Institute on August 30, 2024 and sell it today you would lose (15.00) from holding Oncology Institute or give up 46.87% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy52.17%
ValuesDaily Returns

Oncology Institute  vs.  Novo Integrated Sciences

 Performance 
       Timeline  
Oncology Institute 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncology Institute has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Novo Integrated Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novo Integrated Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Oncology Institute and Novo Integrated Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oncology Institute and Novo Integrated

The main advantage of trading using opposite Oncology Institute and Novo Integrated positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncology Institute position performs unexpectedly, Novo Integrated can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Integrated will offset losses from the drop in Novo Integrated's long position.
The idea behind Oncology Institute and Novo Integrated Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios